Correlation of molecular human leukocyte antigen typing and outcome in high-risk melanoma patients receiving adjuvant interferon-Reference-Cited by-同舟云学术

Correlation of molecular human leukocyte antigen typing and outcome in high-risk melanoma patients receiving adjuvant interferon

Published:2010-06-14 Issue:18 Volume:116 Page:4326-4333
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Gogas Helen,Kirkwood John M.,Falk Christine S.,Dafni Urania,Sondak Vernon K.,Tsoutsos Dimosthenis,Stratigos Alexandros,Markopoulos Christos,Pectasides Dimitrios,Spyropoulou-Vlachou Maria

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.25211/fullpdf

Reference31 articles.

1. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system;Balch;J Clin Oncol.,2001

2. Interferon alfa-2b adjuvant therapy of high-risk respected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684;Kirkwood;J Clin Oncol.,1996

3. High- and low-dose interferon alfa-2b in high-risk melanoma: first analysis of intergroup trial E1690/S9111/C9190;Kirkwood;J Clin Oncol.,2000

4. High-dose interferon alfa-2b significantly prolongs relapse-free and overall survival compared with the GM2 KLH/QS 21 vaccine in patients with resected stage IIB-III melanoma: results of intergroup trial E1694/S9512/C509801;Kirkwood;J Clin Oncol.,2001

5. A pooled analysis of Eastern Cooperative Oncology Group and intergroup trials of adjuvant high-dose interferon for melanoma;Kirkwood;Clin Cancer Res.,2004

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Late-onset toxicities of monoclonal antibodies in cancer patients;Immunotherapy;2022-09

2. Overview of Research on Germline Genetic Variation in Immune Genes and Cancer Outcomes;Cancer Epidemiology, Biomarkers & Prevention;2022-03-01

3. Nucleic acid biomarker technology for cancer immunotherapy;Engineering Technologies and Clinical Translation;2022

4. Development of preclinical and clinical models for immune-related adverse events following checkpoint immunotherapy: a perspective from SITC and AACR;Journal for ImmunoTherapy of Cancer;2021-09

5. Computing Skin Cutaneous Melanoma Outcome From the HLA-Alleles and Clinical Characteristics;Frontiers in Genetics;2020-03-26